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Strengthening the Foundation
of Risk Assessment
The growing controversy over the risk
assessment policies ofU.S. regulatory agen-
cies is emotional and divisive. At the root
of the problem is the huge magnitude of
uncertainty that often accompanies risk
estimates for a given exposure level of an
environmental agent. This uncertainty is
created by weaknesses and/or inadequacies
in the available scientific data and the diffi-
culties in translating biological information
into mathematics. Reliance on default
assumptions that are open to legitimate
criticisms fuels the controversy. Regulatory
agencies are often the victims in risk assess-
ment wars because they must make regula-
tory decisions whether or not appropriate
scientific information is available and
ensure that these decisions protect the pub-
lic from adverse health effects.
NIEHS has a long record of accom-
plishment, through both extramural and
intramural programs, on the mechanisms
whereby chemicals cause disease and on the
relationship between chemical exposure
and adverse health outcomes in humans.
The National Toxicology Program, the
nation's most comprehensive toxicity test-
ing program, is centered at NIEHS and has
contributed substantially to the hazard
identification component of risk assess-:
ment. The major goals of NIEHS in .isk
assessment are 1) to strengthen the sciasitif0
ic foundation onwhich risk assessm
based by increased understanding ofmt0c
anisms and dose-response relationships,
the identification of sensitive subpopula-
tions, and evaluation of the relevance of
animal models for estimating human risks;
2) to develop novel and more reliable
approaches to estimate human risks; 3) to
collaborate with regulatory agencies on
conducting risk assessments; and 4) to
communicate findings to the public in an
understandable and objective way.
Laboratory of Biochemical
Risk Analysis
Although many components of NIEHS
conduct research that is directly relevant to
various aspects of risk assessment, the
Laboratory of Biochemical Risk Analysis
(LBRA) has served as the focus for the
development and application oflaboratory
approaches relevant to risk assessment.
George Lucier has been chief of LBRA
since its inception in 1984. Many notable
contributions have been made by LBRA
scientists, but the most visible is research
on dioxins, genetic susceptibility, and bio-
markers. The work on dioxin has addressed
dose-response relationships and compari-
son of human and rodent responses. The
dose-response studies have demonstrated
that the response to different levels of
exposure to dioxin cannot be predicted
solely on the basis that the response is
receptor mediated. It is generally accepted
that most, ifnot all, ofdiox-
in's effects require interac-
tion with a cellular protein
called the Ah receptor. The
Ah receptor appears to func-
tion like receptors forsteroid
hormones. In a series ofpa-
pers by Lucier and co-
workers Angelika Tritscher,
Charles Sewall, Jack Van-
denHeuvel, and George
Clark, evidence was present-
ed that the amount ofdiox-
in required to activate cellu-
lar enzymes and affect
growth factors is linearly
related to concentrations of
dioxins in certain bqo4m--
sues. It is also clear tbatearianhon ,
probably estrogenrs,ar
in-mediatedli-eAre,
r-ts from whi ttihe ovaries .- h
Iacontrastto data on the atan
Ain eTCDD's effc -
oflivercllsandgrowdtof -
ing cancer cells are not strictly proportional
to the dose ofTCDD. Much ofthe dose-
response work has been conducted on liver,
but the NIEHS work has recently demo
strated that the mechanism responsibl for
TCDD-mediated lung cancer is d e
from that for liver cancer; ovari
mones are necessary for liver cancr but
protect against lung cancer. This findin:i
especially relevant in light ofseveral studs
which demonstrated that dioxin exposure
in the workplace is associated with in->
creased riskofrespiratoy tumors.
LBRA scientists are now attempting to
characterize the flctors that control dose-
response relationships for different effects
mediated by the Ah receptor. LBRA mole-
cular dosimetry studies are now using sen-
sitive methods such as reverse-transcriptase
polymerase chain reaction to detect dioxin-
mediated changes in gene expression for
exposure levels encountered by the overall
population.
One of the important questions con-
cerning risk assessment for dioxins is the
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,QorgeCleri-researching sen-
t dioxins
sensitivity of humans to these compounds.
This issue is being addressed by a large mul-
tilaboratory collaborative study that indudes
George Clark and Angelika Tritscher of
LBRA, Neil Caporaso of the National
Cancer Institute, Larry Needham of CDC;
Maria Teresa Landi and Pier Bertazzi ofthe
University of Milan, Paolo Mocarelli and
Paolo Brambilla of Desio
Hospital, Detlev Jung of the
University of Mainz, Lutz
Edler of the University of
Heidelbur& George Lambert of
Loyola University, Oliver
Hankinson ofthe University
of California-Los Angeles,
and Linda Birnbaum and
Dagmar Lang of EPA. One
goal ofthe study is to identi-
fy human genetic markers
for susceptibility to the toxic
and carcinogenic effects of
dioxins. By characterizing
the receptor and the changes
in gene expression, markers
may be identified that corre-
latewith adverse human health effects.
For this study, two cohorts of people
exposed to high concentrations of dioxins
J~ve heen assembled. One ofthe cohorts is
-tQn~ $o vso, Italy and was exposed to high
iewk tif4ioxins after a chemical plant
e-p1minn in 1976. The second cohort
- is*ers exposed occupationally at
aiplant synthesizing 2,4,5-tri-
and other chemicals contam-
inated with dioxins. Within these cohorts
certain duals developed chloracne, a
skAinlesionthat is a response to dioxin
ex e wereas others exposed to similar
concnrtions did not develop chloracne.
Aling the genetic and biochemical dif-
frences in these people and correlating the
r0slts00to other health effects should pro-
vi insight into the sensitivity ofhumans
to dioxins. LBRA scientists are working
dosely with NIEHS's new Laboratory of
Quantitative and Computational Biology
to develop dose-response models for the
cancer and noncancer effects of dioxins,
described later in this section.
Douglas A. Bell is carrying out studies
on human genetic susceptibility to cancer-
causing agents. Inherited variability in the
ability to detoxify carcinogens has been
associated with increased cancer suscepti-
bility. Presumably, individuals who carry
high-risk genotypes suffer more genetic
damage as a result of chemical exposure,
and this damage translates into greater risk
ofdeveloping cancer.
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NIEHS investigators have developed
sensitive assays to detect susceptibility to
carcinogens in cigarette smoke, foods,
industrial by-products, and environmental
pollution. Based on tests of more than
1000 individuals for these susceptibility
genes, the frequency of the at-risk geno-
types vary significantly among Asians,
Caucasians, and African-Americans. Such
variation suggests that some of the differ-
ences in cancer incidence among ethnic
groups may be due to genetic differences as
well asexposure differences.
In collaboration with Jack Taylor of
the NIEHS Epidemiology Branch, LBRA
is testing the effect ofcertain cancer sus-
ceptibility genes in studies ofbladder can-
cer, lung cancer, and liver cancer. In-
dividuals who carry the at-risk genotype
for glutathione transferase i, an enzyme
that detoxifies constituents of cigarette
smoke, suffer a 70% increased risk ofblad-
der cancer. In ongoing studies with
researchers at the National Cancer In-
stitute, Columbia University, University of
North Carolina, and University of Keele,
England, NIEHS is exploring howgenetic
variability in the metabolism of carcino-
gens affects risk for cancer ofthe bladder,
lung, liver, stomach, colon, head, and
neck.
The cytochrome P450 enzymes cat-
alyze the oxidation of drugs, carcinogens,
and other xenobiotics. Joyce Goldstein's
group in LBRA is looking for genetic de-
fects in these enzymes that affect the ability
ofhumans to metabolize chemical agents.
Population studies have shown that some
people are poor metabolizers ofthe drug S-
mephenytoin, and defective metabolism is
inherited. Metabolism of other drugs,
including barbiturates,
the antimalarials, and the
antiulcer drug omepra-
zole, maybe mediated by
the same enzyme. Gold-
stein's group has isolated
two new genes in the
P450 subfamily. These
studies use conventional
cloning techniques and
polymerase chain reac-
tion to identify genetic
differences in genes from
poor or extensive metab-
olizers ofthe drugs. The
ability of proteins coded
by these genes to metab-
olize drugs and chemi-
cals is being studied by Burhan Ghanayem
ofLBRA.
Laboratory of Quantitative
and Computational Biology
High-speed computing, the improved abii-
ty to collect a broad range of data at the
ICO
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JoyceGoldstein-isolating P450
genes
Acluialtwe-pathAw-sta e moel ofcarcinmgnsis is being developed bymembersofthe LQCB.
biochemical and molecular levels, and
recent advances in mathematics and statis-
tics have significantly enhanced the utility
of mathematical modeling in describing
and studying environmental risks. The
emergence of these new technologies re-
quires a multidisciplinary ap-
proach in the quantitative sci-
ences and creates the need for
research teams in quantitative
and computational areas. To
address this need, NIEHS is cre-
ating a new laboratory, the Lab-
oratory of Quantitative and
Computational Biology (LQCB).
The primary responsibility of
LQCB is to investigate the ap-
plication of mathematics, statis-
tics, computational chemistry,
electrical engineering, and com-
puter science to the understand-
ing ofhuman health risks from
exposure to environmental
agents. LQCB will initially com-
bine scientists from three research groups at
NIEHS: a group developing new method-
ology and applying existing methodology
to the application ofquantum and statisti-
cal mechanics in environmental health, a
group focusing on research in mathematical
modeling aimed at developing new meth-
odologies for risk estimation, and the
NIEHS Scientific Computing Laboratory,
whose primary purpose is computational
support and direction for intramural
research at NIEHS. In addition to these
scientists, the LQCB plans to add expertise
in a variety ofrelated fields, induding arti-
ficial intelligence andvirtual reality. LQCB
will be able to model biological mecha-
nisms at all levels ofcomplexity from mole-
cular to demographic. The collaboration of
LQCB and other NIEHS branches will
lead to more efficient use of NIEHS re-
sources through improved experimental
design and the formal use of data from
multiple sources. Current research and
short-term research plans for the LQCB
can be divided into seven broad areas: car-
cinogenic modeling, molecular modeling,
biochemical and pharmacological model-
ing, modeling noncarcinogenic endpoints,
computer science, artificial intelligence, and
risk communication. Christopher Portier
will beactingchiefofthis newlaboratory.
Challenging a Dioxin
Hypothesis
Dioxin is believed bymanyto be one ofthe
most potent carcinogens in the environ-
ment. Emerging information at the molec-
ular level concerning the mechanism of
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